Andreas Strüngmann: Difference between revisions
Appearance
Content deleted Content added
RjwilmsiBot (talk | contribs) m Adding Persondata using AWB (7319) |
m move link to first instance |
||
Line 1: | Line 1: | ||
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion, making Sandoz the largest generic-drug company in the world. |
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion, making [[Sandoz]] the largest generic-drug company in the world. |
||
He currently has residences in [[Tegernsee]], Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at |
He currently has residences in [[Tegernsee]], Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis. |
||
==See also== |
==See also== |
Revision as of 13:35, 24 June 2011
Andreas Strüngmann (born 1950) was born in Germany and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making Sandoz the largest generic-drug company in the world.
He currently has residences in Tegernsee, Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.
See also
References
External links